FANCA Peptide
€100.00
In stock
SKU
350523
Protein Family: Enzymes
Pathway and Disease: Cancers, Replication and Repair
Alternate Names: Fanconi anemia group A protein; Protein FACA; FANCA; FAA; FACA; FANCH
Accession No.: O15360, NP_000126
Description:
Fanconi anemia group A protein (FANCA) is a DNA repair protein that operates in a postreplication repair or a cell cycle checkpoint function. FANCA is involved in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability. Defects in FANCA are the cause of Fanconi anemia, a syndrome characterized by pancytopenia, congenital malformations and predisposition to cancers caused by a hypersensitivity to DNA-damaging agents, chromosomal instability and defective DNA repair.
Format:
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 1886 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200161 is selected from a sequence within the C-term region of human FANCA. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C76H124N24O30S1
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Pathway and Disease: Cancers, Replication and Repair
Alternate Names: Fanconi anemia group A protein; Protein FACA; FANCA; FAA; FACA; FANCH
Accession No.: O15360, NP_000126
Description:
Fanconi anemia group A protein (FANCA) is a DNA repair protein that operates in a postreplication repair or a cell cycle checkpoint function. FANCA is involved in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability. Defects in FANCA are the cause of Fanconi anemia, a syndrome characterized by pancytopenia, congenital malformations and predisposition to cancers caused by a hypersensitivity to DNA-damaging agents, chromosomal instability and defective DNA repair.
Format:
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 1886 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200161 is selected from a sequence within the C-term region of human FANCA. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C76H124N24O30S1
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
| Is Featured? | No |
|---|
Write Your Own Review